Objectives Lymphatic spread of colorectal cancer cells to regional lymph nodes is one of the early events in metastatic cancers and often is associated with distant metastatic spread and a poor prognosis.In this experiment,the expression levels of lymphatic endothelial markers—VEGF-D,podoplanin,and a newly described tumor marker,TEM-8 were assessed half-quantified by using a real-time PCR(RT-PCR) technique,to evaluate the prognostic value of the three markers in colorectal cancer.methods Tumor tissue and adjacent normal mucosa were obtained from 30 colorectal cancer patients immediately after surgical resection.Levels of VEGF-D, podoplanin and TEM-8 were examined for each sample using real-time RT-PCR.Results VEGF-D,podoplanin,and TEM-8 levels were significantly higher in tumor tissues than that in normal mucosa(VEGF-D level detected in tumor tissue was 0.0055±0.0036,and in normal mucosa,0.0015±0.0015,P<0.05,podoplanin levels in tumor tissues and normal mucosa were 0.0136±0.0106,and 0.0014±0.0018, respectively,P<0.05,and for TEM-8 levels,0.0006±0.0004,in tumor tissues,0.0043±0.0035,in normal mucosa,P<0.05).In the cases with regional lymphnode metastasis,VEGF-D levels were significantly higher than those without(0.00847±0.00218,and 0.00481±0.00108,respectively,P<0.05),but no correlation was found between VEGF-D level and tumor stage(in Dukes B group,VEGF-D level was 0.00486±0.00186,in Dukes C,0.00621±0.00269,P>0.05).While TEM-8(Dukes B,0.0028±0.0141,Dukes C,0.00375±0.0162,P<0.05,lymphnode positive, 0.00415±0.0137,lymphnode negative,0.00213±0.00584,P<0.05) and podoplanin (Dukes B,0.0074±0.0126,Dukes C,0.0171±0.0159,P<0.05,lymphnode positive, 0.0247±0.0218,lymphnode negative,0.00681±0.0108,P<0.05) levels was correlated with both regional node metastasis and tumor stage.Conclusion VEGF-D,Podoplanin and TEM-8 could act as tumor markers for colorectal cancer,and were correlated with regional lymphnode metastasis.TEM-8 was proved to be an tumor spicific marker,may play an important role in the diagnosis,prognostic prediction,and treatment of colorectal cancer.
|